The FDA has classified an earlier Utz recall of select Zapp's and Dirty potato chips as Class I, its most serious recall level, over a potential salmonella risk tied to a seasoning ingredient. The original voluntary recall was issued in May, and no illnesses have been reported.
The FDA has elevated an earlier Utz recall of select Zapp's and Dirty potato chips to Class I, its highest recall classification, over a possible salmonella risk tied to a seasoning ingredient.
The upgrade comes after Utz Quality Foods voluntarily recalled the products in May 2026. Reports on July 2 said the FDA had since classified the recall as the most serious level, which indicates a reasonable probability of serious adverse health consequences or death if the product is used or exposed to.
What Was Recalled
The affected products include select Zapp's Bayou Blackened Ranch, Salt and Vinegar, and Big Cheezy chips, along with Dirty Salt and Vinegar, Maui Onion, and Sour Cream and Onion potato chips.
Reports said the bags were distributed nationwide and carried best-by dates in late July and August 2026.
Why The Recall Was Escalated
The contamination concern centers on dry milk powder used in a seasoning blend and supplied through a third-party vendor. Multiple reports said testing found the ingredient batches negative for salmonella before use, but Utz recalled the chips out of caution after the supplier's recall.
The recall involves the seasoning ingredient rather than the chips themselves.
Public-Health Impact
No illnesses have been reported in connection with the recalled chips so far.
Consumers were advised not to eat the affected products, to throw them away, and to contact Utz for a refund.
What Is Still Unclear
The exact FDA enforcement-report wording and the specific lot, UPC, or batch codes tied to the Class I designation were not confirmed in the reporting reviewed. It was also not clear whether Utz issued a new statement after the FDA upgrade.
The FDA escalation changes the regulatory severity of an already-public recall and may increase retailer removal and consumer awareness while officials continue monitoring for any illness reports or expanded product scope.
Revision note
Initial automated publication.
